T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
TechTarget
TTGT
$277M
| $311K | ﹤0.01% |
12,683
+330
| +3% | +$9.29K |
|
2452
FTAI Infrastructure
FIP
$551M
| $310K | ﹤0.01% |
33,025
+968
| +3% | +$8.99K |
|
2453
NerdWallet
NRDS
$639M
| $310K | ﹤0.01% |
24,315
+1,000
| +4% | +$13.2K |
|
2454
NRC Health Common Stock
NRC
$471M
| $309K | ﹤0.01% |
13,498
+144
| +1% | +$3.25K |
|
2455
Origin Bancorp
OBK
$1.69B
| $309K | ﹤0.01% |
9,602
+365
| +4% | +$11.9K |
|
2456
National Presto Industries
NPK
$987M
| $307K | ﹤0.01% |
4,080
+42
| +1% | +$3.13K |
|
2457
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $306K | ﹤0.01% |
12,230
+348
| +3% | +$8.48K |
|
2458
Old Second Bancorp
OSBC
$1.31B
| $306K | ﹤0.01% |
19,534
+562
| +3% | +$9.04K |
|
2459
Mobileye
MBLY
$7.57B
| $305K | ﹤0.01% |
22,202
-1,800
| -7% | -$31.6K |
|
2460
Marcus & Millichap
MMI
$1.2B
| $305K | ﹤0.01% |
7,675
+246
| +3% | +$9.28K |
|
2461
Sturm, Ruger & Co
RGR
$601M
| $305K | ﹤0.01% |
7,299
-121
| -2% | -$5.11K |
|
2462
Krispy Kreme
DNUT
$569M
| $302K | ﹤0.01% |
28,055
+1,409
| +5% | +$15.3K |
|
2463
Hingham Institution for Saving
HIFS
$686M
| $301K | ﹤0.01% |
1,235
-21
| -2% | -$4.85K |
|
2464
Kodak
KODK
$978M
| $301K | ﹤0.01% |
63,721
| – | – |
|
2465
Mativ Holdings
MATV
$667M
| $301K | ﹤0.01% |
17,680
+696
| +4% | +$12.2K |
|
|
TBI
2466
Trueblue
TBI
$309M
| $301K | ﹤0.01% |
38,053
+215
| +0.6% | +$1.93K |
|
2467
Aldeyra Therapeutics
ALDX
$86.9M
| $300K | ﹤0.01% |
55,622
+7,149
| +15% | +$34K |
|
2468
Camtek
CAMT
$8.06B
| $299K | ﹤0.01% |
3,738
-217,655
| -98% | -$21.2M |
|
|
ETWO
2469
DELISTED
E2open Parent Holdings
ETWO
| $299K | ﹤0.01% |
67,586
+13,697
| +25% | +$59.9K |
|
2470
Enliven Therapeutics
ELVN
$4.25B
| $298K | ﹤0.01% |
11,647
+440
| +4% | +$10.2K |
|
|
PLYM
2471
DELISTED
Plymouth Industrial REIT
PLYM
| $298K | ﹤0.01% |
13,179
+453
| +4% | +$10.5K |
|
|
YMAB
2472
DELISTED
Y-mAbs Therapeutics
YMAB
| $297K | ﹤0.01% |
22,537
+258
| +1% | +$3.27K |
|
2473
RE/MAX Holdings
RMAX
$265M
| $296K | ﹤0.01% |
23,733
+290
| +1% | +$3K |
|
2474
Northrim BanCorp
NRIM
$601M
| $295K | ﹤0.01% |
16,552
-8,060
| -33% | -$132K |
|
2475
Ducommun
DCO
$3.01B
| $294K | ﹤0.01% |
4,451
+168
| +4% | +$10.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.